7 General discussion | 191 107. Aubrey BJ, Strasser A, Kelly GL. Tumor-Suppressor Functions of the TP53 Pathway. Cold Spring Harb Perspect Med. 2016;6(5). doi:10.1101/cshperspect.a026062 108. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003;3(3):155-168. doi:10.1038/ nrc1011 109. Sealey AL, Hobbs NK, Schmidt EE. Molecular genotyping of the mouse scid allele. J Immunol Methods. 2002;260(1-2):303-304. doi:10.1016/s0022-1759(01)00524-5 110. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MT, Danska JS. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 1996;10(16):2038-2054. doi:10.1101/gad.10.16.2038 111. Nahar R, Ramezani-Rad P, Mossner M, et al. Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood. 2011;118(15):4174-4178. doi:10.1182/ blood-2011-01-331181 112. Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature. 2004;432(7017):635-639. doi:10.1038/ nature03147 113. Hu H, Wang B, Borde M, et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol. 2006;7(8):819826. doi:10.1038/ni1358 114. Li S, Wei X, He J, et al. The comprehensive landscape of miR-34a in cancer research. Cancer Metastasis Rev. 2021;40(3):925-948. doi:10.1007/s10555-021-09973-3 115. Luan S, Sun L, Huang F. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Arch Med Res. 2010;41(2):67-74. doi:10.1016/j. arcmed.2010.02.007 116. Tan J, Fan L, Mao JJ, et al. Restoration of miR34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity. J Cell Biochem. 2012;113(9):29032908. doi:10.1002/jcb.24167 117. Chang TC, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007;26(5):745-752. doi:10.1016/j.molcel.2007.05.010 118. Rao DS, O’Connell RM, Chaudhuri A a., Garcia-Flores Y, Geiger TL, Baltimore D. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity. 2010;33(1):48-59. doi:10.1016/j. immuni.2010.06.013 119. Palmer VL, Aziz-Seible R, Kassmeier MD, Rothermund M, Perry GA, Swanson PC. VprBP Is Required for Efficient Editing and Selection of Igκ+ B Cells, but Is Dispensable for Igλ+ and Marginal Zone B Cell Maturation and Selection. J Immunol. 2015;195(4):15241537. doi:10.4049/jimmunol.1500952 120. Kassmeier MD, Mondal K, Palmer VL, et al. VprBP binds full-length RAG1 and is required for B-cell development and V(D)J recombination fidelity. EMBO J. 2012;31(4):945958. doi:10.1038/emboj.2011.455 121. Johnston R, Mathias B, Crowley SJ, et al. Nuclease-independent functions of RAG1 direct distinct DNA damage responses in B cells. EMBO Rep. 2023;24(1):e55429. doi:10.15252/embr.202255429
RkJQdWJsaXNoZXIy MTk4NDMw